Literature DB >> 28639193

miRNA-Mediated RNA Activation in Mammalian Cells.

Ramani Ramchandran1,2, Pradeep Chaluvally-Raghavan3,4.   

Abstract

MicroRNA (miRNA or miR) is a small noncoding RNA molecule ~22 nucleotides in size, which is found in plants, animals, and some viruses. miRNAs are thought to primarily down regulate gene expression by binding to 3' untranslated regions of target transcripts, thereby triggering mRNA cleavage or repression of translation. Recently, evidence has emerged that miRNAs can interact with the promoter and activate gene expression. This mechanism, called RNA activation (RNAa), is a process of transcriptional activation where the direct interaction of miRNA on the promoter triggers the recruitment of transcription factors and RNA-Polymerase-II on the promoter to activate gene transcription. To date, very little is known about the mechanism by which miRNA regulates RNA activation (RNAa) and their role in tumor progression. This is an emerging field in RNA biology. In this chapter, we describe the mechanisms utilized by miRNAs to activate transcription.

Entities:  

Keywords:  Duplex RNA; Promoter and RNA interference (RNAi); RNA activation (RNAa); microRNA

Mesh:

Substances:

Year:  2017        PMID: 28639193     DOI: 10.1007/978-981-10-4310-9_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

1.  Transcription start site-associated small RNAs in the PTEN gene.

Authors:  Ji-Long Liu; Wen-Qian Zhang; Ming-Yu Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-14       Impact factor: 11.205

Review 2.  MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.

Authors:  Mamta Panda; Elora Kalita; Satyendra Singh; Ketan Kumar; Abhishek Rao; Vijay Kumar Prajapati
Journal:  Life Sci       Date:  2022-07-01       Impact factor: 6.780

3.  Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.

Authors:  Michael Friedrich; Christoforos K Vaxevanis; Katharina Biehl; Anja Mueller; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

4.  A Novel Method for Predicting Disease-Associated LncRNA-MiRNA Pairs Based on the Higher-Order Orthogonal Iteration.

Authors:  Zhanwei Xuan; Xiang Feng; Jingwen Yu; Pengyao Ping; Haochen Zhao; Xianyou Zhu; Lei Wang
Journal:  Comput Math Methods Med       Date:  2019-05-02       Impact factor: 2.238

Review 5.  MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.

Authors:  Mohammad Mijanur Rahman; Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

Review 6.  MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics.

Authors:  Anna Sadakierska-Chudy
Journal:  Biomolecules       Date:  2020-09-07

7.  Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study.

Authors:  Reda Albadawy; Sara H A Agwa; Eman Khairy; Maha Saad; Naglaa El Touchy; Mohamed Othman; Mohamed El Kassas; Marwa Matboli
Journal:  Genes (Basel)       Date:  2021-11-18       Impact factor: 4.096

Review 8.  miRNA Landscape in Pathogenesis and Treatment of Vogt-Koyanagi-Harada Disease.

Authors:  Fabian Vega-Tapia; Mario Bustamante; Rodrigo A Valenzuela; Cristhian A Urzua; Loreto Cuitino
Journal:  Front Cell Dev Biol       Date:  2021-05-10

Review 9.  Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.

Authors:  Hongyu Liu; Cheng Lei; Qin He; Zou Pan; Desheng Xiao; Yongguang Tao
Journal:  Mol Cancer       Date:  2018-02-22       Impact factor: 27.401

Review 10.  miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment.

Authors:  Ilaria Conti; Gabriele Varano; Carolina Simioni; Ilaria Laface; Daniela Milani; Erika Rimondi; Luca M Neri
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.